SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-06-035886
Filing Date
2006-02-21
Accepted
2006-02-21 17:17:33
Documents
5
Period of Report
2006-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 40214
2 0.125% INDENTURE DATED FEBRUARY 17, 2006 dex41.htm EX-4.1 529877
3 0.375% INDENTURE DATED FEBRUARY 17, 2006 dex42.htm EX-4.2 531409
4 REGISTRATION RIGHTS AGREEMENT dex43.htm EX-4.3 96189
5 PURCHASE AGREEMENT dex101.htm EX-10.1 206553
  Complete submission text file 0001193125-06-035886.txt   1406074
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 06633942
SIC: 2836 Biological Products, (No Diagnostic Substances)